A citation-based method for searching scientific literature

Samantha Greenberg, Saundra S Buys, Sandra L Edwards, Whitney Espinel, Alison Fraser, Amanda Gammon, Brent Hafen, Kimberly A Herget, Wendy Kohlmann, Camille Roundy, Carol Sweeney. Cancer Med 2019
Times Cited: 5







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
40

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
287
40

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006
438
40

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.
Shan Yang, Jennifer E Axilbund, Erin O'Leary, Scott T Michalski, Robbie Evans, Stephen E Lincoln, Edward D Esplin, Robert L Nussbaum. Ann Surg Oncol 2018
24
40



How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.
Lieke Marleen van den Heuvel, Daphne Stemkens, Wendy A G van Zelst-Stams, Floor Willeboordse, Imke Christiaans. J Genet Couns 2020
4
50

Availability and payer coverage of BRCA1/2 tests and gene panels.
Elizabeth Clain, Julia R Trosman, Michael P Douglas, Christine B Weldon, Kathryn A Phillips. Nat Biotechnol 2015
17
40

What motivates interest in attending a familial cancer genetics clinic?
L Fraser, S Bramald, C Chapman, C Chu, V Cornelius, F Douglas, A Lucassen, A Nehammer, S Sutton, M Trivella,[...]. Fam Cancer 2003
26
40

Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.
Maria C Katapodi, Miyeon Jung, Ann M Schafenacker, Kara J Milliron, Kari E Mendelsohn-Victor, Sofia D Merajver, Laurel L Northouse. JMIR Cancer 2018
10
40


Features of Computer-Based Decision Aids: Systematic Review, Thematic Synthesis, and Meta-Analyses.
Ania Syrowatka, Dörthe Krömker, Ari N Meguerditchian, Robyn Tamblyn. J Med Internet Res 2016
43
40


Development of FamilyTalk: an Intervention to Support Communication and Educate Families About Colorectal Cancer Risk.
Deborah J Bowen, Travis Hyams, Mercy Laurino, Timothy Woolley, Stacey Cohen, Kathleen A Leppig, Gail Jarvik. J Cancer Educ 2020
6
40

Population screening for genetic disorders in the 21st century: evidence, economics, and ethics.
S D Grosse, W H Rogowski, L F Ross, M C Cornel, W J Dondorp, M J Khoury. Public Health Genomics 2010
83
40

Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
Marta Fadda, Pierre O Chappuis, Maria C Katapodi, Olivia Pagani, Christian Monnerat, Véronique Membrez, Sheila Unger, Maria Caiata Zufferey. PLoS One 2020
2
100

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
Adam H Buchanan, Santanu K Datta, Celette Sugg Skinner, Gail P Hollowell, Henry F Beresford, Thomas Freeland, Benjamin Rogers, John Boling, P Kelly Marcom, Martha B Adams. J Genet Couns 2015
78
40

Telegenetics use in presymptomatic genetic counselling: patient evaluations on satisfaction and quality of care.
Ellen Otten, Erwin Birnie, Adelita V Ranchor, Irene M van Langen. Eur J Hum Genet 2016
23
40

Research participants' experiences with return of genetic research results and preferences for web-based alternatives.
Jill B Gaieski, Linda Patrick-Miller, Brian L Egleston, Kara N Maxwell, Sarah Walser, Laura DiGiovanni, Jamie Brower, Dominique Fetzer, Amanda Ganzak, Danielle McKenna,[...]. Mol Genet Genomic Med 2019
9
40

Telegenetics: an Update on Availability and Use of Telemedicine in Clinical Genetics Service.
Irena Vrečar, Dimitar Hristovski, Borut Peterlin. J Med Syst 2017
26
40

Quality of family history collection with use of a patient facing family history assessment tool.
R Ryanne Wu, Tiffany L Himmel, Adam H Buchanan, Karen P Powell, Elizabeth R Hauser, Geoffrey S Ginsburg, Vincent C Henrich, Lori A Orlando. BMC Fam Pract 2014
23
20

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, Anthony V D'Amico, Brian J Davis, Tanya Dorff, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano,[...]. J Natl Compr Canc Netw 2019
426
20


Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
79
20

Malignant Abnormalities in Male BRCA Mutation Carriers: Results From a Prospectively Screened Cohort.
Roy Mano, Shlomit Tamir, Inbal Kedar, Ofer Benjaminov, Jack Baniel, Tzlil Tabachnik, David Margel. JAMA Oncol 2018
11
20

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.
Pål Møller, Anne Irene Hagen, Jaran Apold, Lovise Maehle, Neal Clark, Bent Fiane, Kjell Løvslett, Eivind Hovig, Anita Vabø. Eur J Cancer 2007
82
20


Biomedical databases: protecting privacy and promoting research.
Jean E Wylie, Geraldine P Mineau. Trends Biotechnol 2003
63
20

CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
Juan L Rodriguez, Cheryll C Thomas, Greta M Massetti, Debra Duquette, Lindsay Avner, John Iskander, Muin J Khoury, Lisa C Richardson. MMWR Morb Mortal Wkly Rep 2016
6
20

Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.
Flora Zagouri, Paraskevi Liakou, Rupert Bartsch, Fedro A Peccatori, Alexandra Tsigginou, Constantine Dimitrakakis, George C Zografos, Meletios-Athanassios Dimopoulos, H A Azim. Breast 2015
17
20

Utah family-based analysis: past, present and future.
Lisa A Cannon Albright. Hum Hered 2008
51
20

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan,[...]. J Natl Compr Canc Netw 2016
111
20


Public health action in genomics is now needed beyond newborn screening.
M S Bowen, K Kolor, W D Dotson, R M Ned, M J Khoury. Public Health Genomics 2012
37
20



Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
Sommer Hayden, Sarah Mange, Debra Duquette, Nancie Petrucelli, Victoria M Raymond. J Genet Couns 2017
22
20

Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome.
Angela M Trepanier, Laura Supplee, Lindsey Blakely, Jenna McLosky, Debra Duquette. Healthcare (Basel) 2016
1
100

Evaluating and improving the implementation of a community-based hereditary cancer screening program.
Samantha Greenberg, Beverly M Yashar, Mark Pearlman, Deb Duquette, Kara Milliron, Monica Marvin. J Community Genet 2019
4
25

The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.
Katrina F Trivers, Juan L Rodriguez, Summer L Cox, Barbara E Crane, Debra Duquette. Healthcare (Basel) 2015
11
20

The Integration of Genomics into Public Health Research, Policy and Practice in the United States.
L.M. Beskow, M.J. Khoury, T.G. Baker, J.F. Thrasher. Community Genet 2001
37
20

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
20

Proposed outcomes measures for state public health genomic programs.
Debra Lochner Doyle, Mindy Clyne, Juan L Rodriguez, Deborah L Cragun, Laura Senier, Georgia Hurst, Kee Chan, David A Chambers. Genet Med 2018
6
20

Patterns of cancer genetic testing: a randomized survey of Oregon clinicians.
Summer L Cox, Amy I Zlot, Kerry Silvey, Debi Elliott, Tara Horn, Amber Johnson, Richard F Leman. J Cancer Epidemiol 2012
23
20

Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors.
Tarsha Jones, Joan S Lockhart, Kari E Mendelsohn-Victor, Debra Duquette, Laurel L Northouse, Sonia A Duffy, Rosemary Donley, Sofia D Merajver, Kara J Milliron, J Scott Roberts,[...]. Am J Prev Med 2016
29
20


Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
L Brannon Traxler, Monique L Martin, Alice S Kerber, Cecelia A Bellcross, Barbara E Crane, Victoria Green, Roland Matthews, Nancy M Paris, Sheryl G A Gabram. Ann Surg Oncol 2014
18
20


Current priorities for public health practice in addressing the role of human genomics in improving population health.
Muin J Khoury, Michael S Bowen, Wylie Burke, Ralph J Coates, Nicole F Dowling, James P Evans, Michele Reyes, Jeannette St Pierre. Am J Prev Med 2011
51
20

Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.
Ridgely Fisk Green, Mary Ari, Katherine Kolor, W David Dotson, Scott Bowen, Nancy Habarta, Juan L Rodriguez, Lisa C Richardson, Muin J Khoury. Genet Med 2019
16
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.